Reduced Health Related Quality of Life, Increased Fatigue, and Daytime Sleepiness in Women with Hyperprolactinemia

被引:3
作者
Ernersson, Asa [1 ]
Bachrack-Lindstrom, Margareta [1 ]
Landberg, Eva [2 ,3 ]
Ekman, Bertil [4 ,5 ]
Wahlberg, Jeanette [4 ,5 ,6 ]
机构
[1] Linkoping Univ, Div Nursing Sci & Reprod Hlth, Dept Hlth Med & Caring Sci, Linkoping, Sweden
[2] Linkoping Univ, Dept Clin Chem, Linkoping, Sweden
[3] Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden
[4] Linkoping Univ, Dept Endocrinol, Linkoping, Sweden
[5] Linkoping Univ, Dept Hlth Med & Caring Sci, Linkoping, Sweden
[6] Orebro Univ, Fac Med Sci, Orebro, Sweden
关键词
prolactin; hyperprolactinemia; HRQoL; SF-36; PITUITARY-ADENOMAS; PROLACTIN; SF-36; IMPACT;
D O I
10.1055/a-2042-0712
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Prolactin has many physiological effects and seems to be involved in the human quality of life and well- being. The aim of this study was to describe health related quality of life, fatigue and daytime sleepiness in women with untreated hyperprolactinemia. In total 32 women (mean age 37.0 +/- 10.9 years) with verified hyperprolactinemia completed a questionnaire including questions on fatigue, measured with the Swedish version of the Fatigue Impact Scale ( FIS), propensity to fall in sleep, measured with the Swedish version of the Epworth Sleepiness Scale (ESS), and Health related quality of life (HRQoL), measured by the Short-Form- 36 scale ( SF-36). For comparison Swe-dish normative data were used. The women were also interviewed regarding different symptoms related to hyperprolactinemia and the answers were analyzed using qualitative content analysis. HRQoL, as measured with SF-36, was significantly lower in all dimensions, except in physical function, compared to the Swedish reference population. Total FIS was 54.3 (41.1) and mean score on the ESS was 8.7 (4.2) indicating increased fatigue and deterioration in night sleep. The women felt very tired, and several of them rarely felt rested in the morning. The restless night sleep and the fatigue during the daytime got them to feel feeble and sometimes to find it difficult to concentrate, which affected both their mood and life in general. Women diagnosed with hyperprolactinemia reported deterioration in night sleep, increased rate of fatigue, and a reduced health related quality of life in comparison with the reference population.
引用
收藏
页码:266 / 272
页数:7
相关论文
共 36 条
  • [1] Hyperprolactinemia, prolactin-related side effects and quality of life in Chinese psychiatric patients
    An, Feng-Rong
    Yang, Rui
    Wang, Zhi-Min
    Ungvari, Gabor S.
    Ng, Chee H.
    Chiu, Helen F. K.
    Wu, Ping-Ping
    Jin, Xin
    Li, Lu
    Lok, Grace K. I.
    Xiang, Yu-Tao
    [J]. COMPREHENSIVE PSYCHIATRY, 2016, 71 : 71 - 76
  • [2] Towards a better quality of life (QoL) for patients with pituitary diseases: results from a focus group study exploring QoL
    Andela, Cornelie D.
    Niemeijer, Nicolasine D.
    Scharloo, Margreet
    Tiemensma, Jitske
    Kanagasabapathy, Shaaji
    Pereira, Alberto M.
    Kamminga, Noelle G. A.
    Kaptein, Ad. A.
    Biermasz, Nienke R.
    [J]. PITUITARY, 2015, 18 (01) : 86 - 100
  • [3] The Effects of Antipsychotics on Prolactin Levels and Women's Menstruation
    Bargiota, S. I.
    Bonotis, K. S.
    Messinis, I. E.
    Angelopoulos, N. V.
    [J]. SCHIZOPHRENIA RESEARCH AND TREATMENT, 2013, 2013
  • [4] Rotating night shift work, sleep quality, selected lifestyle factors and prolactin concentration in nurses and midwives
    Bukowska, Agnieszka
    Sobala, Wojciech
    Peplonska, Beata
    [J]. CHRONOBIOLOGY INTERNATIONAL, 2015, 32 (03) : 318 - 326
  • [5] Health-Related Quality of Life in Pituitary Diseases
    Crespo, Iris
    Valassi, Elena
    Santos, Alicia
    Webb, Susan M.
    [J]. ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2015, 44 (01) : 161 - +
  • [6] Quality of life in women with microprolactinoma treated with dopamine agonists
    de Oliveira Naliato, Erika Cesar
    Dutra Violante, Alice Helena
    Caldas, Dayse
    Filho, Adilson Lamounier
    Loureiro, Christiane Rezende
    Fontes, Rosita
    Schrank, Yolanda
    de Souza, Rodrigo Gomes
    Vaisman, Mario
    Guerra, Ermelinda
    Sebastian, Arantzazu
    Colao, Annamaria
    [J]. PITUITARY, 2008, 11 (03) : 247 - 254
  • [7] Clinical and biological characterization of macroprolactinemia with and without prolactin-IgG complexes
    De Schepper, J
    Schiettecatte, J
    Velkeniers, B
    Blumenfeld, Z
    Shteinberg, M
    Devroey, P
    Anckaert, E
    Smitz, J
    Verdood, P
    Hooghe, R
    Hooghe-Peters, E
    [J]. EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2003, 149 (03) : 201 - 207
  • [8] The roles of prolactin, growth hormone, insulin-like growth factor-I, and thyroid hormones in lymphocyte development and function: Insights from genetic models of hormone and hormone receptor deficiency
    Dorshkind, K
    Horseman, ND
    [J]. ENDOCRINE REVIEWS, 2000, 21 (03) : 292 - 312
  • [9] Immunomodulating Effects Depend on Prolactin Levels in Patients with Hyperprolactinemia
    Ewerman, Lea
    Landberg, Eva
    Hellberg, Sandra
    Hovland, Mina
    Sundin, Anna
    Jenmalm, Maria C.
    Ekman, Bertil
    Ernerudh, Jan
    Wahlberg, Jeanette
    [J]. HORMONE AND METABOLIC RESEARCH, 2020, 52 (04) : 228 - 235
  • [10] The prevalence of pituitary adenomas - A systematic review
    Ezzat, S
    Asa, SL
    Couldwell, WT
    Barr, CE
    Dodge, WE
    Vance, ML
    McCutcheon, IE
    [J]. CANCER, 2004, 101 (03) : 613 - 619